CDW · CDW Corporation

Current Thesis

CDW Corporation’s enterprise artificial-intelligence (AI) recovery depends on stronger sales translating into steadier margins and cash generation; third-quarter results test that conversion. The price expression of the thesis is a weekly close above $161.30, the adjusted 52-week high reported as of 2026-09-18, before a weekly close below $120 invalidates the recovery.

The inference is that the narrative is maturing — Barclays raised its target to $150 on 2026-09-08 while retaining Equal-Weight, and the 2026-09-18 relative strength index over 14 periods (RSI) was 48.4 despite an 18.9% three-month price increase. These observations support a recovery awaiting operating confirmation; they do not establish expanding participation. Barclays target revision

The Lovelytics announcement remains the company-specific extension of the story. CDW’s 2026-09-02 release valued the proposed acquisition at approximately $525 million and said it would not materially affect 2026 results. The acquisition therefore supplies strategic evidence, while the next earnings report must supply the near-term financial evidence. CDW acquisition announcement

Bullish and bearish views on CDW Corporation

The model's bull view on CDW Corporation (CDW), in brief: Demand reached reported sales. CDW reported second-quarter 2026 net sales of $6.572 billion, up 10.0% year over year, on 2026-08-05. Gross profit increased 6.3%, showing that the additional volume generated additional gross-profit dollars despite the weaker margin. CDW quarterly… The bear view: Margins lagged revenue growth. The 2026-08-05 release put second-quarter gross margin at 20.1%, compared with 20.8% a year earlier, while operating income increased 2.0%. Sales growth has therefore not translated proportionately into operating profit. CDW quarterly results Cash… Both cases follow in full.

Bull Case

• Demand reached reported sales. CDW reported second-quarter 2026 net sales of $6.572 billion, up 10.0% year over year, on 2026-08-05. Gross profit increased 6.3%, showing that the additional volume generated additional gross-profit dollars despite the weaker margin. CDW quarterly results
• Services capability gains substance. The 2026-09-02 Lovelytics announcement described an expansion of CDW’s data, analytics and AI capabilities through a Databricks consulting partner. That supports the services component of the thesis, although the announcement supplied no Lovelytics revenue or earnings figure. CDW acquisition announcement
• Analyst valuation moved higher. Barclays raised its CDW target to $150 on 2026-09-08 while maintaining Equal-Weight. This is a dated valuation revision, with no accompanying rating upgrade. Barclays revision

Bear Case

• Margins lagged revenue growth. The 2026-08-05 release put second-quarter gross margin at 20.1%, compared with 20.8% a year earlier, while operating income increased 2.0%. Sales growth has therefore not translated proportionately into operating profit. CDW quarterly results
• Cash conversion remains unresolved. StockStory’s 2026-08-05 earnings summary reported second-quarter free cash flow of negative $251.4 million, versus positive $210.1 million a year earlier. Another negative quarter would contradict the cash-recovery component of the thesis.
• Acquisition economics remain undisclosed. CDW’s 2026-09-02 announcement gave approximately $525 million of transaction value without Lovelytics revenue or earnings. The disclosed information cannot establish an acquisition earnings multiple or quantify future accretion. CDW acquisition announcement

Setup & Price Structure

The adjusted market close was $146.19 on 2026-09-18, with the shares up 18.9% over three months and 9.4% below the reported $161.30 52-week high. These are measured price observations. A weekly close above that high defines the recovery’s price-confirmation condition; it has not been achieved at the reference close.

The $120 threshold retains the public recovery boundary identified in the 2026-09-05 dossier. It is a thesis-break condition, not a newly measured moving average. Current moving-average distances, volume participation, short interest and retail-flow measurements are unavailable in the dated evidence; the sample is too small to support a crowding claim.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Lovelytics closing-window endpoint. CDW’s 2026-09-02 announcement expected completion during the third quarter. September 30 marks that window’s endpoint, not a company-announced closing appointment; an announced delay beyond the quarter would contradict the stated timetable. CDW acquisition announcement

As of 2026-09-19, an exact acquisition closing date and a company-confirmed third-quarter earnings date have not been established. The 2026-09-08 conference date has elapsed. Third-quarter results remain the financial test, but no estimated earnings appointment is presented as confirmed.

What Would Change Our Mind

Failure of the recovery structure would end the price thesis: a weekly close below $120 breaches the boundary published on 2026-09-05. Independently, third-quarter gross margin below the second quarter’s 20.1%, or another quarter of negative free cash flow, would reject the operating-stabilization case anchored to the 2026-08-05 results.

The maturing assessment would also need revision if a weekly close above the 2026-09-18 high of $161.30 coincided with higher gross-profit guidance. Completion of Lovelytics alone would not establish that improvement, because CDW’s 2026-09-02 announcement explicitly excluded a material contribution to 2026 results.

Correlation Notes

This remains a single-name setup. CDW’s 2026-08-05 results link its demand to infrastructure modernization, cloud and AI-enabled technology, but those business exposures do not measure share-price correlation with other AI companies. No matched peer-return series is available as of 2026-09-18, so the evidence supports neither a correlation coefficient nor a claim that a group advance confirms CDW’s recovery. CDW results announcement